Bayer U.S. studies shed further light on menopause care
National surveys explore the menopause experience and need for individualized care.
Pharmacy
NPC issues new white paper on 340B Drug Pricing Program
Increases in 340B hospital purchases are associated with $137 in additional annual employer-sponsored premium costs for single coverage and $415 for family coverage.
Thousands attend Asembia's AXS25 Specialty Pharmacy Summit in Las Vegas
Annual Conference links industry to specialty pharmacy's role at center of patient access, prescription fulfillment, and affordability.
NCPA: Any pharma tariffs should be tailored to avoid increasing shortages and costs
NCPA is urging the Trump administration to establish certain exclusions from any tariffs, incentivize U.S. manufacturing through supportive domestic and trade policies, and reform the PBM payment model to strengthen domestic supply chains and reimburse pharmacies fairly.
NACDS urges strategic tariff plan to ensure medication access
“Our members serve as healthcare lifelines in communities nationwide — we cannot afford disruptions that leave pharmacy shelves empty,” says NACDS president and CEO.
USP: Long-lasting drug shortages drive average duration higher, disrupting patient care
Persistent U.S. shortages make up most of the total, despite a decline in new shortages.
Cardinal Health releases new report on the cell and gene therapy industry
Analysis charts the emergence and future of advanced therapies.
CVS offering varied store formats to meet community needs
The goal is to have the right kind and number of stores in the right locations to better serve their customers’ needs.
New GoodRx report dives into shrinking insurance coverage
Medicaid is the most generous in coverage (97%), but also the most restrictive (63% of drugs have hurdles to access).
Camber Launches Eslicarbazepine Acetate Tablets
Eslicarbazepine Acetate Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
NACDS Foundation welcomes new members to its board of directors
Directors from Unilever, Kroger Health, Inmar Intelligence, Haleon, Colgate-Palmolive, and Walmart to support the Foundation’s ongoing focus on research and education.
Learn Look Locate, Pfizer and Imerman Angels launch global initiative to expand access to Stage 4 breast cancer advances
Delivering cutting-edge treatment insights and one-on-one mentor support for metastatic breast cancer patients worldwide.
Walmart Canada launches in-store pharmacy clinics in Canada
The first pharmacy clinic opens in St. Catharines, Ontario with plans to launch more in select provinces later this year.
NACDS praises Governor Youngkin, Virginia lawmakers for transformative move to “single PBM”
Save Our Pharmacies Act Deliversnew transparency and access for Virginia Medicaid patients.
Pharmacies excluded from preferred networks face much higher risk of closure
Study reveals how Medicare Part D networks managed by PBMs are contributing to widespread pharmacy closures.
NACDS hails introduction of H.R. 3164 to expand pharmacist services for medicare beneficiaries
Bipartisan bill positions pharmacies as vital healthcare access points for seniors, driving solutions for healthier communities.